[
  {
    "ts": null,
    "headline": "Is Moderna Stock a Buy?",
    "summary": "Moderna's (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off.  Despite what it seems, though, Moderna has made clinical and regulatory progress.  Let's find out whether this scenario is realistic for Moderna.",
    "url": "https://finnhub.io/api/news?id=01b2d4724faa5cdeb9fe4f5bf9bf87693b58679d6120ab90f206cc24b24523cc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734695100,
      "headline": "Is Moderna Stock a Buy?",
      "id": 132073998,
      "image": "https://g.foolcdn.com/editorial/images/800896/nurse-vaccinating-elderly-patient.jpg",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna's (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off.  Despite what it seems, though, Moderna has made clinical and regulatory progress.  Let's find out whether this scenario is realistic for Moderna.",
      "url": "https://finnhub.io/api/news?id=01b2d4724faa5cdeb9fe4f5bf9bf87693b58679d6120ab90f206cc24b24523cc"
    }
  },
  {
    "ts": null,
    "headline": "3 Stocks That Could Turn $1,000 into $5,000 by 2030",
    "summary": "Moderna's (NASDAQ: MRNA) market cap currently stands at around $14.8 billion.  To become a five-bagger, the messenger RNA (mRNA) pioneer would need to grow its market cap to $74 billion.  The good news for Moderna is that it's already proven it can reach that level.",
    "url": "https://finnhub.io/api/news?id=87bba117a2231cb7c953d51bd6d0b3f5f60bf3c9482313b84bcd23a4764adfb8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734688200,
      "headline": "3 Stocks That Could Turn $1,000 into $5,000 by 2030",
      "id": 132073538,
      "image": "https://g.foolcdn.com/editorial/images/801402/cheering-person-with-laptop.jpg",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna's (NASDAQ: MRNA) market cap currently stands at around $14.8 billion.  To become a five-bagger, the messenger RNA (mRNA) pioneer would need to grow its market cap to $74 billion.  The good news for Moderna is that it's already proven it can reach that level.",
      "url": "https://finnhub.io/api/news?id=87bba117a2231cb7c953d51bd6d0b3f5f60bf3c9482313b84bcd23a4764adfb8"
    }
  }
]